Form 4: ONTO Innovation CEO Sells 35,000 Shares Under 10b5-1 Trading Plan

ONTO Innovation CEO Michael Plisinski sold 35,000 shares of common stock at a weighted average price of $219.19, as part of a pre-arranged 10b5-1 trading plan.

Summary

• Michael Plisinski, CEO of ONTO Innovation Inc., sold 35,000 shares of common stock on January 21, 2025.
• The sale was executed under a Rule 10b5-1 trading plan adopted on August 26, 2024.
• The shares were sold at a weighted average price of $219.19.
• The sale was executed in multiple transactions with prices ranging from $219 to $219.52 per share.
• Following the transaction, Mr. Plisinski directly owns 150,492 shares of ONTO Innovation stock.

Sentiment

Score: 5

Explanation: The document reports a routine stock sale by the CEO under a pre-arranged plan. It is neither particularly positive nor negative, and is a normal part of executive compensation and portfolio management.

Risks

• Executive stock sales can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Executive stock sales are a common occurrence, and the use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading. This transaction is not unusual for a company of this size and stage.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to manage their stock sales in a compliant manner.
• Similar transactions are regularly reported by executives at comparable technology companies, such as Applied Materials and Lam Research.
• The volume of shares sold is not unusual for an executive at this level, and the price range is consistent with the current market valuation of ONTO Innovation.

Stakeholder Impact

• The stock sale may have a minor impact on shareholder sentiment, but is unlikely to cause a significant change in the stock price given the pre-arranged nature of the transaction.

Key Dates

Keywords

ONTO Innovation, Michael Plisinski, stock sale, Rule 10b5-1, insider trading, executive stock, share transaction